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A RECEPTOR FOR THE THIRD COMPONENT OF COMPLEMENT
IN THE HUMAN RENAL GLOMERULUS
By MICHAEL C . GELFAND, MICHAEL M. FRANK, AND IRA GREEN
(From the Division ofNephrology, Department ofMedicine, Georgetown University Medical Center,
Washington D . C . 20007; and the Laboratory of Clinical Investigation and the Laboratory of
Immunology, National Institute ofAllergy and Infectious Diseases, National Institutes of Health,
Bethesda, Maryland 20014)
In the course of studying the nature of mononuclear cellular infiltrates in
tissue sections of human kidney it was noted that indicator sheep erythrocytes
densely coated with the third component of complement (C3) specifically ad-
heredto all of the glomeruli in the tissue sections . The deposition ofcomplement
(C) within the glomerulus is a feature of many immunologically related renal
diseases (1, 2), yet the precise mechanism by which C is deposited remains
unexplained . We feel that this observation, suggesting the presence of a receptor
for C, is, therefore, of particular interest.
Materials and Methods
Buffers consisted of veronal-buffered saline with added Ca++, Mg++, and 0.15 W gelatin (VBS)
and a low ionic strength buffer of dextrose in VBS with added Call, Mg++, and gelatin (0.065 w)
(DVBS) (3) .
Sheeperythrocytes (E) were sensitized with highly purified rabbit IgM anti-Forssman antibody
as previously described (4) . In experiments with erythrocytes exposed to fresh mouse serum, 5 x
10" cells/ml were incubated with a 1/10 dilution of CDF, mouse serum for 30 min at 37°C to form
EAC. These cells were then thoroughly washed.
Cellular intermediates in the C system were prepared by either of two methods using compo-
nents of guinea pig or human C. In each case C4, C2, andC3 were either all of guinea pig or all of
human origin . Either EA or EAC4 (t_ <5 min) were exposed to partially purified guinea pig C1
(1,000 site-forming units (SFU)/cell) to form EAC1 or EAC14, respectively, and then were washed
with DVBS (3) .
Washed EAC1 were mixed with partially purified human or guinea pig C4 (Cordis Laborato-
ries, Miami, Fla.), 100 SFU/cell, and incubated at 37°C for 30 min . The mixture was brought to
30°C . Human or guinea pig C2 (100 SFU/cell) and human or guinea pig C3 (Cordis Laboratories)
(2-200 SFU/cell) were added . These mixtures were incubated at 30°C for 1handthen washed twice
in DVBS .
EAC14 were mixedwith 100 SFU/cell of C2 (human or guinea pig) . After 10 min at 30°C, C3 was
added (100-1,000 SFU/cell) . The mixtures were reincubated at 30°C for 1 h. EA which had been
exposed to Cl, C4, C2, and C3 by either method were coated with Cab as evidenced by a positive
immune adherence reaction and by their agglutination by an anti-C3b antiserum .
To cleave cell-bound C3b these cells were exposed to a source of the C3b inactivator, either
whole serum heated at 56°C for 30 min or the partially purified human C3b inactivator (Cordis
Laboratories) . Equal volumes of EAC1423b (1 .5 x 10" cells/ml in DVBS) and undiluted heated
serum or undiluted partially purified inactivator were combined . After 1-2h at 37°C the cells were
washed and resuspended to a density of 1.5 x 10" cells/ml . These cells were tested by immune
adherence and were only used when this reaction was negative . Representative samples of these
cells had surface C3d as indicated by agglutination with anti-C3d antibody . Attempts were made
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to block the adherence of Cab-coated erythrocytes with partially purified Cab. EAC14 prepared
with guinea pig reagents were mixed with excess partially purified guinea pig C2 and C3 and
incubated for 2 h at 37°C . Underthese conditions erythrocyte-bound C3 convertase is formed and
cleaves C3 into its two major fragments, C3a and Cab. A portion ofthe Cab attaches to EAC142 to
form the cell intermediate EAC1423b . Themajority ofthe C3b remains in thesupernatant fluid as
fluid-phaseC3b. Theresulting supernate wasused as the source of guinea pig C3b. As acontrol in
which no Cab is generated, partially purified C2 and C3 were mixed and incubated in the absence
of EAC142 .
To determine the degree of adherence between the erythrocyte reagents and tissue sections, 8
gin frozen sections of unfixed tissue were cutwith a cryostat andallowed to air dry. The sections
were layered with the various indicator erythrocyte reagents (1 .5 x 10" cells/ml) and incubated in
a moist chamber at room temperature for 15 min. The slides were then washed in phosphate-
buffered saline to remove nonadherent erythrocytes . The resultant preparations were fixed for 15
minin Perfix (Applied Bioscience, Patterson, N. J.), stainedwith Giemsa, and examined by light
microscopy (5, 6) .
Results
Sheep erythrocytes (SRBC) showed no binding to human renal tissue sections .
Similarly, SRBC coated with only IgM anti-Forssman antibody showed no
adherence (Fig . 1 a) . In contrast, SRBC coated with IgM anti-Forssman anti-
body which were then incubated in fresh mouse serum as a source of C, showed
specific glomerular localization (Figs . 1 b and c) . Each of 12 autopsy specimens
examined was positive and demonstrated binding to virtually all glomeruli
present in the section . No binding was observed to interstitial structures .
Autopsy specimens were obtained between 3 and 36 h after death and were
frozen in O . C . T . embedding compound (Ames Co ., Div . of Miles Lab ., Inc .,
Elkhart, Ind .) at -40°C for subsequent evaluation . The ages of the patients at
the time of death ranged from 1 day to 82 yr . None of the patients died as a result
of renal disease .
EA treated with mouse serum incubated at 56°C for 30 min showed no renal
glomerular adherence, suggesting that the presence of activated C on the
reagent erythrocyte was required for adherence . To verify that the heat-labile
serum component was indeed C, a series of erythrocyte reagents were prepared
with partially purified human or guinea pig C components and their adherence
was examined. In these experiments no binding was observed with erythrocytes
coated with IgM antibody and the first (C1) and 4th (C4) components of C .
However, the addition to the EAC14 cells ofC2 plus C3 ofguinea pig or human
origin led to specific glomerular localization (Table I) of these cells . Indicator
cells prepared under these conditions have large amounts ofC3 on their surface
and this is an essential requirement for binding .
The next experiments were performed to determine which fragment of C3 was
required for glomerular binding . EA reacted with purified C1, C4, C2, and C3 are
known to have deposited C3b on their surface (EAC1423b) (7) . In the presence of
heated serum (a source of C3 inactivator) or partially purified C3 inactivator,
C3b is cleaved to C3c and C3d ; the latter remains bound to the indicator cell
surface (8, 9) . EAC1423b-coated cells were exposed to either heated (56°C, 1/2 h)
serum or partially purified human C3 inactivator for 1-2 h at 37°C . As shown in
Table II, these cells (EAC1423d) demonstrated no specific glomerular localiza-
tion, although such cells could be shown to be heavily coated with C3d using
specific anti-C3d antibody .FIG . 11032 GELFAND ET AL .
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TABLE I
Characterization ofC Components Required for Glomerular
Binding
Indicator cells
￿
Binding
E
￿
0
IgMEA
￿
0
IgMEAC 1
￿
0
IgMEAC14
￿
0
IgMEAC1423
￿
...
Indicator SRBC coated with IgM anti-Forssman antibody were prepared with
partially purified guinea pig C components after which they were layered on
frozen sections of human kidney and their binding to glomeruli evaluated .
TABLE II
Determination of the C3 Fragment Required for Binding
IgMEAC 1423b were incubated with heated serum (56°C for 30 min) or partially
purified C3 inactivator . These reagents were layered on frozen sections of kidney
which were untreated or preincubated with either soluble C2 and C3 (containing
little C3b) or C3b. The binding of the erythrocyte reagents to the glomeruli was
then evaluated .
These results suggest that C3b is required for glomerular localization of the
indicator erythrocytes . To further demonstrate the specificity of the glomerular
C3 receptor for Cab, an attemptwas made to inhibit the adherence of C3b-coated
inciator SRBC by prior incubation of the kidney section with soluble Cab . As
shown in Table 11, prior incubation for 1/2 h with soluble C2 + C3 (containing
little C3b) failed to block subsequent binding of C3b-coated cells . However, prior
incubation with a soluble Cab almost completely blocked subsequent binding of
EAC or C3b-coated indicator cells .
The species specificity of the required C was explored . C obtained from all
species tested including mouse, human, and guinea pig was effective in mediat-
ing this reaction . We next investigated the pathway requirement for C3 deposi-
tion . In the experiments reported above, EAC1423b were formed by classical
pathway activation . The adherence of indicator particles coated with Cab via
activation of the alternate pathway was also demonstrated using a technique
FIG . 1 .
￿
(a) Portion of a glomerulus incubated with IgMEA cells . No adherent indicator
IgMEA erythrocytes are present . x 100. (b) Portion of a glomerulus treated with IgM-
EAC1423b ; interstitial areas including tubules are negative . Adherent indicator erythro-
cytes are present selectively over glomeruli . A similar result was observed when whole
mouse serum was used as a source of C . x 100 . (c) A portion of a glomerulus and
surrounding tissue treated with IgMEAC1423b . Adherent indicator erythrocytes are pre-
sent over glomerulus on the left . Tubule on rightshowsno adherent indicator erythrocytes .
x 400.
Preincubation of Preincubation of Binding to IndicatorIgMEAC- kidney sections glomeruli 1423b with :
None None +++
Heated serum None 0
C3 inactivator None 0
None Soluble C2 plus C3 ++
None Soluble C3b 0GELFAND ET AL .
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not reported in detail here (10) . In brief, fluorescent bacteria were incubated in
normal human serum as a source of alternate pathway components . Under
these conditions, the bacteria spontaneously activate C3 via the alternate
pathway and the C3b can be shown to coat the bacterial cell wall . Such
fluoresceinated C3b-coated bacteria adhered to the glomeruli . Moreover, -fluores-
ceinated bacteria incubated in heat-inactivated serum did not . Thus, C3b-coated
indicator cells adhered selectively to the glomerulus whether activated via the
classical or the alternate pathway . Preliminary attempts to demonstrate a C3
receptor in the glomeruli of rats, mice, guinea pigs, rhesus monkeys, rabbits,
and dogs using similar reagents and techniques were unsuccessful .
Discussion
In this communication we have demonstrated that indicator erythrocytes
bearing the activated third component of complement (C3b) are bound selec-
tively to human renal glomeruli in tissue sections . Indicator cells not containing
C3b are not bound . In addition, prior incubation of the tissue section with
soluble C3b almost completely blocks subsequent adherence of indicator cells
containing C3b . Binding of SRBC coated densely with C3b was observed in all
apparently undiseased kidney autopsy specimens examined, including that
from a 1-day old child . C3b-coated SRBC have also been shown to bind to splenic
B-cell germinal centers in tissue sections (5), however glomerular localization of
C3b-coated SRBC in tissue sections requires far more erythrocyte-bound C3b
than does splenic germinal center localization (M . C . Gelfand, M . M . Frank, and
I . Green, unpublished observations) . The exact location ofthe C3 receptor within
the human glomerulus is not yet known, however, preliminary observations
suggest a localization on the surface of the endothelial cell (Raymond Nagle,
unpublished observation) .
The importance of the demonstration of such a receptor for C in the human
glomerulus lies in its potential elucidation of the pathogenesis of immune
complex deposition in glomeruli . A feature ofimmune complex glomerulonephri-
tis is the deposition of C-contained complexes in the glomerulus leading to C-
mediated immune injury (1, 2) . The present finding suggests that a possible
mechanism for this is the selective fixation of C3b-bearing immune complexes to
the glomerular C receptor . Thus, antigen-antibody complexes containing C3b
activated via the classical pathway (analogous to EAC) or complexes containing
C3b produced by alternate pathway activation (analogous to C3-coated fluores-
cent bacteria) may be selectively localized within the glomerulus rather than in
other capillary beds .
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